Mendiola et al. clarify that activated CD4+ T lymphocytes in bone marrow exacerbate insulin resistance and bone loss in type 2 diabetes mellitus (T2DM), which amplifies the importance of T lymphocytes in bone metabolism [4]. This evidence concerns the gene CD4 and type 2 diabetes mellitus.